Dmitry Balyasny’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-97,500
Closed -$3.49M – 1749
2018
Q2
$3.49M Buy
+97,500
New +$3.45M 0.02% 767

Other funds holding EDIT

Dmitry Balyasny's EDIT Position: Q3 2026 in Review

Dmitry Balyasny sold out of Editas Medicine (EDIT) in Q3 2026, closing a stake of 37,638 shares — an estimated $122K sold.

Dmitry Balyasny first reported a position in EDIT in Q3 2016 and held it in 17 quarters. The position peaked at $3.72M in Q2 2022. 219 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Dmitry Balyasny reported no remaining Editas Medicine position as of Q3 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 37,638 Editas Medicine shares in Q3 2026, an estimated $122K.
  • Dmitry Balyasny first reported a position in Editas Medicine in Q3 2016 and held it in 17 quarters.
  • Dmitry Balyasny's Editas Medicine position peaked at $3.72M in Q2 2022.
  • 219 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.